fstop123 / iStockphoto.com
The filing of patent cases related to Abbreviated New Drug Applications (ANDAs) soared at the US District Court for the District of Delaware last year, while filings dramatically fell in the US District Court for the Eastern District of Virginia.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Lex Machina, patent litigation, ANDA, Hatch-Waxman, patent, pharmaceutical
